A Phase 3 Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety
Comparison of Fixed-Dose Ranges (mg/kg/day) of Tomoxetine with Placebo in Child and Adolescent Outpatients with ADHD, Aged 8 to 18 Years
Not available
Attention Deficit Hyperactivity Disorder
Phase 3
A link to and a NCT ID number are not available for this study because the study was conducted before regulatory requirements to register studies.
November 2014